AAAAAA

   
Results: 1-20 |
Results: 20
COMPLEX APOLIPOPROTEIN B-CONTAINING LIPOPROTEIN PARTICLES ARE ASSOCIATED WITH A HIGHER RATE OF PROGRESSION OF HUMAN CHRONIC RENAL-INSUFFICIENCY
Authors: SAMUELSSON O ATTMAN PO KNIGHTGIBSON C LARSSON R MULEC H WEISS L ALAUPOVIC P
Citation: O. Samuelsson et al., COMPLEX APOLIPOPROTEIN B-CONTAINING LIPOPROTEIN PARTICLES ARE ASSOCIATED WITH A HIGHER RATE OF PROGRESSION OF HUMAN CHRONIC RENAL-INSUFFICIENCY, Journal of the American Society of Nephrology, 9(8), 1998, pp. 1482-1488
THE EFFECT OF METABOLIC CONTROL ON RATE OF DECLINE IN RENAL-FUNCTION IN INSULIN-DEPENDENT DIABETES-MELLITUS WITH OVERT DIABETIC NEPHROPATHY
Authors: MULEC H BLOHME G GRANDE B BJORCK S
Citation: H. Mulec et al., THE EFFECT OF METABOLIC CONTROL ON RATE OF DECLINE IN RENAL-FUNCTION IN INSULIN-DEPENDENT DIABETES-MELLITUS WITH OVERT DIABETIC NEPHROPATHY, Nephrology, dialysis, transplantation, 13(3), 1998, pp. 651-655
EFFECTS OF TICLOPIDINE IN AV-FISTULA SURGERY IN UREMIA
Authors: GRONTOFT KC LARSSON R MULEC H WEISS LG DICKINSON JP
Citation: Kc. Grontoft et al., EFFECTS OF TICLOPIDINE IN AV-FISTULA SURGERY IN UREMIA, Scandinavian journal of urology and nephrology, 32(4), 1998, pp. 276-283
HOMOCYSTEINE IS ELEVATED IN RENAL-INSUFFICIENCY BUT IT DOES NOT PREDICT THE RATE OF PROGRESSION
Authors: LEE DM SAMUELSSON O ATTMAN PO KNIGHTGIBSON C MULLEN K LARSSON R MULEC H WEISS LG ALAUPOVIC P
Citation: Dm. Lee et al., HOMOCYSTEINE IS ELEVATED IN RENAL-INSUFFICIENCY BUT IT DOES NOT PREDICT THE RATE OF PROGRESSION, Circulation, 98(17), 1998, pp. 209-209
INITIAL DECREASE IN PROTEINURIA AFTER INSTITUTION OF ACE-INHIBITOR TREATMENT PREDICTS LONG-TERM PROGNOSIS FOR KIDNEY-FUNCTION IN OVERT DIABETIC NEPHROPATHY
Authors: MULEC H JOHNSEN SA CARLSTROM J BJORCK S
Citation: H. Mulec et al., INITIAL DECREASE IN PROTEINURIA AFTER INSTITUTION OF ACE-INHIBITOR TREATMENT PREDICTS LONG-TERM PROGNOSIS FOR KIDNEY-FUNCTION IN OVERT DIABETIC NEPHROPATHY, Journal of the American Society of Nephrology, 8, 1997, pp. 552-552
LIPOPROTEIN ABNORMALITIES ARE ASSOCIATED WITH INCREASED RATE OF PROGRESSION OF HUMAN CHRONIC RENAL-INSUFFICIENCY
Authors: SAMUELSSON O MULEC H KNIGHTGIBSON C ATTMAN PO KRON B LARSSON R WEISS L WEDEL H ALAUPOVIC P
Citation: O. Samuelsson et al., LIPOPROTEIN ABNORMALITIES ARE ASSOCIATED WITH INCREASED RATE OF PROGRESSION OF HUMAN CHRONIC RENAL-INSUFFICIENCY, Nephrology, dialysis, transplantation, 12(9), 1997, pp. 1908-1915
DELETION INSERTION POLYMORPHISM OF THE ANGIOTENSIN-CONVERTING ENZYME GENE AND PROGRESSION OF DIABETIC NEPHROPATHY
Authors: BJORCK S BLOHME G SYLVEN C MULEC H
Citation: S. Bjorck et al., DELETION INSERTION POLYMORPHISM OF THE ANGIOTENSIN-CONVERTING ENZYME GENE AND PROGRESSION OF DIABETIC NEPHROPATHY, Nephrology, dialysis, transplantation, 12, 1997, pp. 67-70
EFFECT OF GEMFIBROZIL ON LIPOPROTEIN ABNORMALITIES IN CHRONIC RENAL-INSUFFICIENCY - A CONTROLLED-STUDY IN HUMAN CHRONIC RENAL-DISEASE
Authors: SAMUELSSON O ATTMAN PO KNIGHTGIBSON C KRON B LARSSON R MULEC H WEISS L ALAUPOVIC P
Citation: O. Samuelsson et al., EFFECT OF GEMFIBROZIL ON LIPOPROTEIN ABNORMALITIES IN CHRONIC RENAL-INSUFFICIENCY - A CONTROLLED-STUDY IN HUMAN CHRONIC RENAL-DISEASE, Nephron, 75(3), 1997, pp. 286-294
DIFFERENT ACTION OF TRIGLYCERIDE-RICH AND CHOLESTEROL-RICH APO B-CONTAINING LIPOPROTEINS ON PROGRESSION OF RENAL-FAILURE
Authors: SAMUELSSON O KNIGHTGIBSON C LARSSON R MULEC H WEISS L ALAUPOVIC P ATTMAN PO
Citation: O. Samuelsson et al., DIFFERENT ACTION OF TRIGLYCERIDE-RICH AND CHOLESTEROL-RICH APO B-CONTAINING LIPOPROTEINS ON PROGRESSION OF RENAL-FAILURE, Journal of the American Society of Nephrology, 7(9), 1996, pp. 391-391
PLASMA-LEVELS OF LIPOPROTEIN (A) DO NOT PREDICT PROGRESSION OF HUMAN CHRONIC-RENAL-FAILURE
Authors: SAMUELSSON O ATTMAN PO KNIGHTGIBSON C LARSSON R MULEC H WEDEL H WEISS L ALAUPOVIC P
Citation: O. Samuelsson et al., PLASMA-LEVELS OF LIPOPROTEIN (A) DO NOT PREDICT PROGRESSION OF HUMAN CHRONIC-RENAL-FAILURE, Nephrology, dialysis, transplantation, 11(11), 1996, pp. 2237-2243
LIPID ABNORMALITIES CONTRIBUTE TO ACCELERATED PROGRESSION OF HUMAN CHRONIC GLOMERULONEPHRITIS
Authors: SAMUELSSON O ATTMAN PO KNIGHTGIBSON C LARSSON R MULEC H WEISS L ALUAPOVIC P
Citation: O. Samuelsson et al., LIPID ABNORMALITIES CONTRIBUTE TO ACCELERATED PROGRESSION OF HUMAN CHRONIC GLOMERULONEPHRITIS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 402-402
LP(A) AND PROGRESSION OF RENAL-INSUFFICIENCY
Authors: SAMUELSSON O ATTMAN PO KNIGHTGIBSON C LARSSON R MULEC H WEISS L ALAUPOVIC P
Citation: O. Samuelsson et al., LP(A) AND PROGRESSION OF RENAL-INSUFFICIENCY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 402-402
PROGRESSION OF OVERT DIABETIC NEPHROPATHY (DN) - ROLE METABOLIC CONTROL
Authors: MULEC H BLOHME G GRANDE B BJORCK S
Citation: H. Mulec et al., PROGRESSION OF OVERT DIABETIC NEPHROPATHY (DN) - ROLE METABOLIC CONTROL, Journal of the American Society of Nephrology, 6(3), 1995, pp. 453-453
SUCCESSFUL KIDNEY-TRANSPLANTATION AFTER SUPPRESSION OF HLA ALLOANTIBODIES WITH INTRAVENOUS IMMUNOGLOBULIN IN A HIGHLY SENSITIZED PATIENT
Authors: WADSTROM J GANNEDAHL G BERSZTEL A BENGTSSON M NATTORP K MULEC H
Citation: J. Wadstrom et al., SUCCESSFUL KIDNEY-TRANSPLANTATION AFTER SUPPRESSION OF HLA ALLOANTIBODIES WITH INTRAVENOUS IMMUNOGLOBULIN IN A HIGHLY SENSITIZED PATIENT, Transplantation proceedings, 27(6), 1995, pp. 3463-3464
LATENT OVERHYDRATION AND NOCTURNAL HYPERTENSION IN DIABETIC NEPHROPATHY
Authors: MULEC H BLOHME G KULLENBERG K NYBERG G BJORCK S
Citation: H. Mulec et al., LATENT OVERHYDRATION AND NOCTURNAL HYPERTENSION IN DIABETIC NEPHROPATHY, Diabetologia, 38(2), 1995, pp. 216-220
A FREE PATIENT CHOICE OF TREATMENT FOR ESRD RESULTS IN HIGH PREVALENCE AND HIGH TECHNIQUE SURVIVAL IN CAPD
Authors: CARLSTROM J NATTORP K MULEC H
Citation: J. Carlstrom et al., A FREE PATIENT CHOICE OF TREATMENT FOR ESRD RESULTS IN HIGH PREVALENCE AND HIGH TECHNIQUE SURVIVAL IN CAPD, Journal of the American Society of Nephrology, 5(3), 1994, pp. 437-437
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Authors: ALTMAN R CARRERAS L DIAZ R FIGUEROA E PAOLASSO E PARODI JC CADE JF DONNAN G EADIE MJ GAVAGHAN TP OSULLIVAN EF PARKIN D RENNY JTG SILAGY C VINAZZER H ZEKERT F ADRIAENSEN H BERTRANDHARDY JM BRAN M DAVID JL DRICOT J LAVENNEPARDONGE E LIMET R LOWENTHAL A MORIAU M SCHAPIRA S SMETS P SYMOENS J VERHAEGHE R VERSTRAETE M ATALLAH A BARNETT H BATISTA R BLAKELY J CAIRNS JA COTE R CROUCH J EVANS G FINDLAY JM GENT M LANGLOIS Y LECLERC J NORRIS J PINEO GF POWERS PJ ROBERTS R SCHWARTZ L SICURELLA J TAYLOR W THEROUX P TURPIE AG WEISEL RD CUI J LIU L PIRK J BAY C BOYSEN G KNUDSEN JB PETERSEN P SORENSEN PS TONNESEN HK HARJOLA PT ARCAN JC BALKAU B BLANCHARD J BOISSEL JP BONEU B BOUSSER MG BROCHIER M CLOAREC M CRIBIER G DECHAVANNE M DROUIN P ESCHWEGE E GUIRAUDCHAUMEIL B HUGONOT R LEIZOROVICZ A LORIA Y MICHAT L MIROUZE J PANAK E PASTEYER J RASCOL A REVOL L ROY M SELLES J SLAMA G STARKMAN C TEULE M THIBULT N VERRY M ALBERT FW ANDRASSY K BREDDIN K ECKEL R ENCKE A FROHLICH J HARTUNG B HEISS HW HESS H HOFLING B KRAUSE D LATTA G LINKE H LOEW D LORENZ R MIDDLETON K NOVAK G OLDENDORF M PFLUGER N RAITHEL D REUTER R SCHETTLER G SCHNITKER J SCHOOP W STIEGLER H UBERLA K VOGEL G WEBER M WELBERS I ZEITLER E ARAPAKIS G CHAN T MOK CK SZABO R MISRA NP REDDY K FITZGERALD GA APOLLONIO A BALSANO F BASELLINI A CANDELISE L CATALANO M CIAVARELLA N CIUFFETTI G COCCHERI S CORTELLARO M CORVI G COTO V DAVI G DECATERINA R DIPERRI T FIESCHI C GENTILE R GREGORATTI L GRESELE P LAVEZZARI M LIBRETTI A MAGNANI B NENCI G PAGANO G PATRONO C PEDRINI L PINI M PRANDONI P ROMEO F ROVELLI F RUDELLI G RUVOLO G SIGNORINI GP TOGNONI G VIOLI F FUJIMORI T KAGEYAMA M KATSUMURA T KITAMURA S MAEDA K SUZUKI A TOHGI H UCHIYAMA S UTSUMI H GARCIA AM ALGRA A DENOTTOLANDER GJH KUPPER AJF VANGIJN J HART H KAPPELLE LJ KOUDSTAAL PJ LEMMENS T LODDER J PANNEBAKKER M SERRUYS PW VANDENBELT A VANDERMEER J VANDERVIJGH AB VERHEUGT FWA VETH G DALE J JOHANNESSEN KA THAULOW E POPESCU P TIBERIU N AZNAR JRD ESMATJES E GUITERAS P LASIERRA J LOPEZTRIGO P ORIOL A POMAR L ROCHA E SANCHEZ FD SANCHORIEGER J SANZ G BERGLUND ULF BLOMSTRAND C BOBERG M BRITTON M ELWIN CE HELMERS C HOLM J JANZON L JUULMOLLER S MULEC H OLSSON JE PERSSON S RASMANIS G ROSEN A SAMUELSSON K SOREFF J WAHLGREN N WALLENTIN L BAUR HR BOKSLAG M BOLLINGER A MEIER B PFISTERER M PFLUGER N SITTHIAMORN C ACHESON EJ APPLEBY P ASSCHER AW AUKLAND A BAIGENT C BALA S BARNETT AH BELL P BEWS S BORN GVR BRANAGAN JP BROOKS N BROWN MJ BROWSE NL CAPILDEO R CARMALT M CARTER AE CHALMERS I CLARKE M CLARKE RJ CLYNE CAC COLLINS R COOKE ED COUTTS G COVE DH CROWTHER PS CUTHBERTSON WF DEBONO D DICKERSON C DICKINSON JP DOLL R DORMANDY JA DUNBABIN D ELL S ELPHINSTONE P ELWOOD P ENGLISHBY V FARRELL B FISKERSTRAND C FLATHER M FOLEY T FOULDS T FOX KM FRANKS P FRASER H GARDECKI T GAWEL M GENT AE GERSHLICK AH GODWIN J GOLDMAN M GRAY C GRAY D GRAY R HANDOLL H HANKEY G HARRISON MJG HENDERSON N HEPTINSTALL S HOBBIGER SF JONES EW JONES NAG JOST S JULIAN D KELLETT J KESTER RC LOWE G MACKENZIE J MCCOLLUM CN MEAD G MEADE TW MENDELOW D MILLER JC MORRIS GK NICHOL C NOBLE M OBRIEN JR OGIER M PARISH S PARRY MJ PETO R POWELL J POZZILLI P QIZILBASH N RAHMAN A RAJAH SM RICHARDS DH RICHARDS S RIPLEY R ROBERTS VC ROSE FC RUSSELL RWR RUBIN PC RUCKLEY CV SANDERCOCK P SHAW MDM SHAW KM SHELLEY JH SLATTERY J SLEIGHT P SMITH SJ STEWARTLONG P SWEETNAM PM TANSEY MJB TINDALL H TURNEY J TYLER HM VAREY NC VESSEY MP WALKER MG WALKER MA WARLOW CP WILCOX RG WILLEMS H WOOD EH WYNJONES E ADAMS HP BARTON B BEDFORD RF BICK BL BINGHAM S BROWN BG BRYANT T BURING J CABOT CF CANNER P CHESEBRO J CHRISMAN OD CLAGETT GP COLWELL JA DYKEN M ELLIS D FIELDS WS FURBERG C FUSTER V GOLDMAN S GRANETT J GREEN RM GREEN D HARDY R HARKER LA HARRIS WH HART RG HASS WK HENNEKENS C HILL D HUME M IGLOE MC JOHNSON G JONAS S KNATTERUD G KOHLER TR LEMBO NJ LEWIS D LOCKHART E MAJERUS P MCENANY MT MCKENNA R MEHTA JL MEYER JS MOLONY B MORITZ T NICOLOFF DM NYCZ G ONO H PANTELY GA PHILLIPS SJ RIDKER P ROBERTSON JT ROTHBART R SALZMAN EW SAUTTER RD SCHLANT RC SCHOENBERGER JA SENGEKONTACKET MV SHARMA G STEELE P STEINNAGEL KP STRATTON J SULLIVAN JM TIMMIS G TOOLE JF WALKER MD WEISMAN S WHITE CW WIRECKI M WOMBOLT D WONG R YUSUF S ZADINA K ZUCKER D
Citation: R. Altman et al., COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS, BMJ. British medical journal, 308(6921), 1994, pp. 81-100
LIPOPROTEIN ABNORMALITIES WITHOUT HYPERLIPIDEMIA IN MODERATE RENAL-INSUFFICIENCY
Authors: SAMUELSSON O ATTMAN PO KNIGHTGIBSON C KRON B LARSSON R MULEC H WEISS L ALAUPOVIC P
Citation: O. Samuelsson et al., LIPOPROTEIN ABNORMALITIES WITHOUT HYPERLIPIDEMIA IN MODERATE RENAL-INSUFFICIENCY, Nephrology, dialysis, transplantation, 9(11), 1994, pp. 1580-1585
LONG-TERM ENALAPRIL TREATMENT IN DIABETIC NEPHROPATHY
Authors: MULEC H JOHNSEN SA BJORCK S
Citation: H. Mulec et al., LONG-TERM ENALAPRIL TREATMENT IN DIABETIC NEPHROPATHY, Kidney international, 45, 1994, pp. 190000141-190000144
CHOLESTEROL - A RENAL RISK FACTOR IN DIABETIC NEPHROPATHY
Authors: MULEC H JOHNSEN SA WIKLUND O BJORCK S
Citation: H. Mulec et al., CHOLESTEROL - A RENAL RISK FACTOR IN DIABETIC NEPHROPATHY, American journal of kidney diseases, 22(1), 1993, pp. 196-201
Risultati: 1-20 |